POSITIVE INTERIM PET AFTER 2 ABVD IS MORE FREQUENT IN PATIENTS WITH UNFAVOURABLE STAGE I/II HODGKIN LYMPHOMA AND BULKY MEDIASTINUM THAN IN NON-BULKY. THE EORTC-GELA-IIL H10 TRIAL EXPERIENCE. THE EORTC-GELA-IIL H10 TRIAL EXPERIENCE

被引：0
|
作者：
Yeddes, I [1 ]
Meignan, M. [1 ]
Bardet, S. [1 ]
Vander Borght, T. [1 ]
Ricci, R. [1 ]
Itti, E. [1 ]
Lumbroso, J. [1 ]
Edeline, V [1 ]
Olivier, P. [1 ]
Borght, T., V [1 ]
Reman, O. [1 ]
Karcher, G. [1 ]
Mundler, O. [1 ]
Hutchings, M. [1 ]
Versari, A. [1 ]
Bellei, M. [1 ]
Raemaekers, J. M. M. [1 ]
Andre, M. [1 ]
机构：
[1] CHU Henri Mondor, Dept Nucl Med, Creteil, France
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P164
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 7 条
  • [1] COMPARISON OF VISUAL AND QUANTITATIVE ASSESSMENT FOR FDG-PET INTERPRETATION IN HODGKIN LYMPHOMA AFTER 2 CYCLES OF ABVD. THE EORTC-GELA-IIL H10 TRIAL EXPERIENCE
    Jullian, A.
    Meignan, M.
    Itti, E.
    Bardet, S.
    Edeline, V
    Vanderborght, T.
    Reman, O.
    Ricci, R.
    Brusamolino, E.
    Raemaekers, J. M. M.
    Andre, M.
    HAEMATOLOGICA, 2010, 95 : S49 - S49
  • [2] Single institution preliminary experience on dose reduction to organs at risk in thoracic radiotherapy for patients enrolled in EORTC-GELA-IIL H10 study protocol on early stage Hodgkin's Lymphoma
    Filippi, A. R.
    Ciammella, P.
    Namsyl-Kaletka, A.
    Botticella, A.
    Todisco, L.
    Fiandra, C.
    Ragona, R.
    Vitola, U.
    Ricardi, U.
    EJC SUPPLEMENTS, 2009, 7 (02): : 158 - 159
  • [3] The H10 EORTC/GELA randomized intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma
    Andre, M.
    Raemaekers, J.
    Van der Maazen, R.
    Reman, O.
    Van't Veer, M.
    Lutgenburg, E.
    Girinski, T.
    Ferme, C.
    Brice, P.
    Casasnovas, O.
    Meignan, M.
    Auduin, J.
    Bosq, J.
    Mounier, N.
    Van Glabekke, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 7 - 7
  • [4] First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/H Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).
    Andre, Marc P. E.
    Reman, Oumedaly
    Federico, Massimo
    Brice, Pauline
    Brusamolino, Ercole
    Girinski, Theodore
    Ferme, Christophe
    vander Maazen, Richard
    Bellei, Monica
    Sebban, Catherine
    Morschhauser, Franck
    Lugtenburg, Elly
    Stamatoullas, Aspasia
    Baila, Liliana
    Fortpied, Catherine
    Meignan, Michel
    Raemaekers, John M.
    BLOOD, 2009, 114 (22) : 44 - 45
  • [5] Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial
    Cottereau, Anne Segolene
    Versari, Annibale
    Loft, Annika
    Casasnovas, Rene-Olivier
    Bellei, Monica
    Ricci, Romain
    Bardet, Stephane
    Castagnoli, Antonio
    Brice, Pauline
    Raemaeker, John
    Itti, Emmanuel
    Forpied, Catherine
    Raveloarivahy, Tiana
    Girinsky, Theodore
    Van der Borght, Thierry
    Federico, Massimo
    Hutchings, Martin
    Ricardi, Umberto
    Meignan, Michel
    Andre, Marc
    BLOOD, 2016, 128 (22)
  • [6] Early FDG-PET Adapted Treatment Improves the Outcome of Early FDG-PET-Positive Patients With Stages I/II Hodgkin Lymphoma (HL): Final Results of the Randomized Intergroup EORTC/LYSA/FIL H10 Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 16 - 17
  • [7] Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
    Raemaekers, John M. M.
    Andre, Marc P. E.
    Federico, Massimo
    Girinsky, Theodore
    Oumedaly, Reman
    Brusamolino, Ercole
    Brice, Pauline
    Ferme, Christophe
    van der Maazen, Richard
    Gotti, Manuel
    Bouabdallah, Reda
    Sebban, Catherine J.
    Lievens, Yolande
    Re, Allessandro
    Stamatoullas, Aspasia
    Morschhauser, Frank
    Lugtenburg, Pieternella J.
    Abruzzese, Elisabetta
    Olivier, Pierre
    Casasnovas, Rene-Olivier
    van Imhoff, Gustaaf
    Raveloarivahy, Tiana
    Bellei, Monica
    van der Borght, Thierry
    Bardet, Stephane
    Versari, Annibale
    Hutchings, Martin
    Meignan, Michel
    Fortpied, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) : 1188 - +
1